Feeds:
Posts
Comments

Archive for the ‘Friday Collection’ Category

After Hours

Happy skies, part 1, part 2.

Really bad timing.

Templar University.

Advertisements

Read Full Post »

After Hours 10_20

The most bizarre “We’re Open for Business” sign ever.

Ever wondered what the sun looked like – up close and personal? Wonder no more!

If your Sales Training dept. ran your Church – very funny!

Combine fall leaves with a slow shutter speed and a camera twist. Result: this! (from my iPhone).

Read Full Post »

After Hours 10_03

Old, creepy ads. Including baby with razor, and “Smoking is Believing.” Creepy is right.

If this isn’t about the strangest wallpaper design, I don’t know what is. Those of you marketing an OAB drug might really like it!

Breathtaking photo: colors of the moon. Plus, a whole gallery of other astro photos from the menu at the left. Awesome stuff.

You might never before have wondered what it looked like when an iron ball is dropped into sand. You mean you actually did wonder? Well, see it in slow-mo. Fascinating!

Reblog this post [with Zemanta]

Read Full Post »

A tale of teen courage. Wow – don’t miss this.

Spider webs and dew drops (pix)…awesome!

Top pictures from the Beijing Olympics – some real beautiful stuff here. And, since London is next up in 2012, some fabulous “overhead” shots of London at night.

Tired of 5,000% markups on eyeglasses? Interesting article on how you can purchase on the Internet nowadays…for WAY less.

A brilliant outdoor advertising campaign. Dang, I wish I’d thought of this!

Do you pass the T-shirt test?

And…hopefully about 60 of you enjoyed barbecuing with Ragin’ Raven BBQ sauce this past weekend! I sure did!

Reblog this post [with Zemanta]

Read Full Post »

J&J found not liable in Motrin case – Johnson & Johnson on Thursday won a lawsuit brought by the family of an 11-year-old girl who became blind after using the drug Children’s Motrin in 2003…more

Preemption reversed? – US District Court Judge David Hamilton has reversed his prior opinion in which he had dismissed a Paxil suicide case based on preemption, which says that FDA approval supercedes state law claims challenging safety, efficacy, or labeling. The FDA and drugmakers argue preemption exists by maintaining agency actions are the final word on safety and effectiveness. The case is now re-opened…more

Teva pays Barr tab – The world’s largest maker of generic drugs is expanding once again. Teva has agreed to pay $66.50, or a total of $7.46 billion plus the assumption of net debt of approximately $1.5 billion…more

AZ and Ethical pharma – AstraZeneca is training staff in a new Code of Conduct that aims to ensure employees at all levels and locations act appropriately. The Code was introduced in May and covers a number issues, including interactions with healthcare professionals, conflicts of interest and the ethics of R&D. It goes further than the recently revised EFPIA or PhRMA rules and explicitly spells out dos and don’ts on additional issues, such as political donations and insider trading…more

You’ve heard about the HR helicopter? Some folks take this literally.

PhRMA says, “Bag the Schwag” – A ubiquitous element of pharmaceutical marketing is scheduled to vanish next January 1, as the revised marketing code of the Pharmaceutical Research and Manufacturers of America goes into effect. Gone will be the non-educational freebies—the pens, pads, mugs, toys, and miscellaneous tchotchkes?that pharma companies distribute by the carload…more. And more here from Pharmalot.

The Washington D.C. rules and regs for pharma sales reps.

Glaxo to pay billions for a good night’s sleep – The drugmaker has agreed to pay that much for the licensing rights to Actelion’s investigational drug, almorexant…more

BI cutting neuro sales force – The neurology sales team, which peddles Aggrenox to neurologists for treating transient ischemic attacks and strokes, met last week in Chicago, where BI managers told them they are going to restructure…more

Zemanta Pixie

Read Full Post »

Breaking news from the ACC:

Vytorin/Zetia gets panned – shows no benefit on the primary endpoint, though effective in reducing some markers. Doctors now wary and skeptical. Merck and Schering-Plough comment. Good summary with more links from Ed Silverman (Pharmlot blog – one of the best btw!) here.
Prasugrel gets a boost – The investigational antiplatelet drug prasugrel plus aspirin produced a marked and highly statistically significant reduction in the risk of coronary stent thrombosis (ST) – a major concern for physicians and patients with potentially fatal consequences – in patients who received a stent as compared to standard therapy with clopidogrel (Plavix®) plus aspirin (1.13 percent vs. 2.35 percent, p<0.0001), according to a stent analysis from the head-to-head TRITON-TIMI 38 trial…more. And, more here from Pharmalot.

Angiomax: pretty much equivalent to heparin – A study released on Saturday found the two drugs worked about the same in low- to moderate-risk patients in preventing death, heart attack and the need to repeat medical intervention on a diseased blood vessel…more

Positive results for AstraZeneca’s cholesterol-reducer CrestorAstraZeneca Plc is stopping a clinical trial of its blockbuster cholesterol fighter Crestor early because of the clear benefits of the medicine compared to placebo, the company said on Monday…more

——OK, now on to other news:

Free drug samples – higher prescription costs? – Following free drug sample receipt, patients who receive these samples have significantly higher out-of-pocket prescription costs than those who don’t, according to the first study to look at the out-of-pocket cost associated with free-sample use…more

Wyeth cutting 1,200 sales reps – The positions are being eliminated as of Monday as part of a major companywide program announced two months ago to save money in the face of regulatory setbacks and generic competition. At the time, the drugmaker acknowledged plans to cut about 10 percent of its global workforce of 50,000 or so, and that sales reps were high on the list. Wyeth employs roughly 25,000 people in the US…more

Sanofi-Aventis to give daily Cialis a boostSanofi-Aventis of France is partnering with Eli Lilly of America’s heartland to give Lilly’s impotence pill Cialis a boost over here…more

Speaking of Sanofi and Lilly: Lantus shows better efficacy than Humalog – A once-daily injection of Sanofi-Aventis‘s insulin drug Lantus controls blood sugar as effectively as Eli Lilly‘s Humalog, which needs to be taken three times daily, researchers said on Friday…more

Singulair trouble – suicide link? – The Food and Drug Administration said Thursday it is investigating a possible link between Merck‘s best-selling Singulair and suicide. FDA said it is reviewing a handful of reports involving mood changes, suicidal behavior and suicide in patients who have taken the popular allergy and asthma drug…more

Takeda drops cholesterol drug candidate lapaquistatTakeda Pharmaceutical Co Ltd, Japan’s biggest drug maker, on Friday dropped development of a cholesterol-lowering drug candidate that had once been seen as one of its most promising medicines…more

Otsuka pays for fraudulent Abilify marketing Otsuka American Pharmaceutical, the US unit of the Japanese drugmaker, agreed to pay more than $4 million to resolve allegations that it marketed the Abilify antipsychotic for off-label uses…more

Disease-mongering brought to a whole new level (are these people serious)? – Anyone familiar with involuntary emotional expression disorder? This is another way of saying uncontrollable laughing or crying, and a little drugmaker called Avanir Pharmaceuticals hopes to market a pill for this “distinct neurological disorder.” Also known as pseudobulbar affect, the affliction has gotten talked up in recent years and investors are buying into the concept…more

The Vytorin studies – what will be revealed at the ACC meeting? Good news from the Enhance study? And why is the Improve-It study being expanded/delayed? Is it for sound data gathering reasons, or is it a conspiracy?

Physician gifting crackdown? – The latest legislative maneuver to control pharmaceutical marketing: Last week, congressman Pete Defazio (D-OR) introduced the Physician Payment Sunshine Act, a bill that will create a public registry of gifts and payments to physicians in excess of $25 by pharmaceutical companies…more

Lunesta moth flying away.

Did you know there are now 30 job openings listed in the Impactiviti Job Board?

Read Full Post »

After Hours 2_23

A fascinating Flash animation showing 5,000 years of history in 90 seconds – specifically, the various empires that have ruled the Middle East. Very cool!

What does it look like when a bullet goes through 3 water balloons? Like this!

Panorama of Paris at night. Breathtaking.

Did you miss the lunar eclipse last week? Check out this spectacular photo.

Read Full Post »

Older Posts »